In order to prove the anti-tumor effect of Diazinon in BC, we used it to treat breast cancer cells and observed that it increased the expression of TAT while suppressing the expression of CDC6, RPA3, POLD1, and POLD2 (Figure 6B). This evidence concerns the gene POLD1 and breast carcinoma.